Naftifine Completed Phase 4 Trials for Tinea Corporis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02227290Pediatric Subjects With Tinea Corporis
NCT02466867An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis